Dietel M - Search Results

1

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Weinstein R. Beck WT, et al. Among authors: dietel m. Cancer Res. 1996 Jul 1;56(13):3010-20. Cancer Res. 1996. PMID: 8674056 Review.

2

Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.

Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M. Stein U, et al. Among authors: dietel m. Int J Cancer. 2002 Feb 20;97(6):751-60. doi: 10.1002/ijc.10131. Int J Cancer. 2002. PMID: 11857350

3

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA. Ross DD, et al. Among authors: dietel m. J Natl Cancer Inst. 1999 Mar 3;91(5):429-33. doi: 10.1093/jnci/91.5.429. J Natl Cancer Inst. 1999. PMID: 10070941

4

Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme.

Holm PS, Scanlon KJ, Dietel M. Holm PS, et al. Among authors: dietel m. Br J Cancer. 1994 Aug;70(2):239-43. doi: 10.1038/bjc.1994.286. Br J Cancer. 1994. PMID: 7914421 Free PMC article.

5

Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.

Dietel M, Herzig I, Reymann A, Brandt I, Schaefer B, Bunge A, Heidebrecht HJ, Seidel A. Dietel M, et al. J Cancer Res Clin Oncol. 1994;120(5):263-71. doi: 10.1007/BF01236382. J Cancer Res Clin Oncol. 1994. PMID: 7907333

6

Molecular mechanisms and possibilities of overcoming drug resistance in gastrointestinal tumors.

Dietel M. Dietel M. Recent Results Cancer Res. 1996;142:89-101. doi: 10.1007/978-3-642-80035-1_7. Recent Results Cancer Res. 1996. PMID: 8893337 Review.

7

Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257.

Dietel M, Arps H, Lage H, Niendorf A. Dietel M, et al. Cancer Res. 1990 Sep 15;50(18):6100-6. Cancer Res. 1990. PMID: 1975514

8

Second International Symposium on Cytostatic Drug Resistance.

Dietel M. Dietel M. Cancer Res. 1993 Jun 1;53(11):2683-8. Cancer Res. 1993. PMID: 8098662 No abstract available.

9

Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells.

Lage H, Dietel M. Lage H, et al. Among authors: dietel m. J Cancer Res Clin Oncol. 2002 Jul;128(7):349-57. doi: 10.1007/s00432-002-0349-y. Epub 2002 Jun 26. J Cancer Res Clin Oncol. 2002. PMID: 12136248

10

Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy.

Holm PS, Lage H, Bergmann S, Jürchott K, Glockzin G, Bernshausen A, Mantwill K, Ladhoff A, Wichert A, Mymryk JS, Ritter T, Dietel M, Gänsbacher B, Royer HD. Holm PS, et al. Among authors: dietel m. Cancer Res. 2004 Jan 1;64(1):322-8. doi: 10.1158/0008-5472.can-0482-2. Cancer Res. 2004. PMID: 14729641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters